Recombinant DNA Technology Market Research Report - Forecast to 2027

Recombinant DNA Technology Market Research Report: By Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food & Agriculture, Health & Disease), End-User (Biotechnology Companies, Pharmaceuticals) – Forecast to 2027

ID: MRFR/LS/4389-HCR | August, 2022 | Region : Global

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Recombinant DNA Technology Market, by Product

6.1 Introduction

6.2 Medical

6.2.1 Market Estimates & Forecast, 2020-2027

6.2.2 Therapeutic Agent

6.2.2.1 Market Estimates & Forecast, 2020-2027

6.2.3 Human Protein

6.2.3.1 Market Estimates & Forecast, 2020-2027

6.2.4 Vaccine

6.2.4.1 Market Estimates & Forecast, 2020-2027

6.3 Non-Medical

6.3.1 Market Estimates & Forecast, 2020-2027

6.3.2 Biotech Crops

6.3.2.1 Market Estimates & Forecast, 2020-2027

6.3.3 Specialty Chemicals

6.3.3.1 Market Estimates & Forecast, 2020-2027

6.3.4 Others

6.3.4.1 Market Estimates & Forecast, 2020-2027

6.4 Others

Chapter 7. Global Recombinant DNA Technology Market, by Component

7.1 Introduction

7.2 Expression System

7.2.1 Market Estimates & Forecast, 2020-2027

7.2.2 Mammalian

7.2.2.1 Market Estimates & Forecast, 2020-2027

7.2.3 Bacteria

7.2.3.1 Market Estimates & Forecast, 2020-2027

7.2.4 Yeast

7.2.4.1 Market Estimates & Forecast, 2020-2027

7.2.4 BaculovirU.S./Insect

7.2.4.1 Market Estimates & Forecast, 2020-2027

7.2.5 Others

7.2.5.1 Market Estimates & Forecast, 2020-2027

7.3 Cloning Vector

7.3.1 Market Estimates & Forecast, 2020-2027

7.3.2 Plasmid

7.3.2.1 Market Estimates & Forecast, 2020-2027

7.3.3 Phage

7.3.3.1 Market Estimates & Forecast, 2020-2027

7.3.4 Cosmid

7.3.4.1 Market Estimates & Forecast, 2020-2027

7.3.5 Bacterial Artificial Chromosome (BAC)

7.3.5.1 Market Estimates & Forecast, 2020-2027

7.3.6 Yeast Artificial Chromosome (YAC)

7.3.6.1 Market Estimates & Forecast, 2020-2027

7.3.7 Human Artificial Chromosome (HAC).

7.3.7.1 Market Estimates & Forecast, 2020-2027

7.4 Others

Chapter 8. Global Recombinant DNA Technology Market, by Application

8.1 Introduction

8.2 Food & Agriculture

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Health & Disease

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Environment

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Others

Chapter 9. Global Recombinant DNA Technology Market, by End-U.S.er

9.1 Introduction

9.2 Biotechnology Companies

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Academic & Government Research Institutes

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Pharmaceuticals

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 Others

Chapter .8 Global Recombinant DNA Technology Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.1 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 U.K.

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 Republic of Korea

8.4.6 Rest of Asia Pacific

8.5 The Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of the Middle East & Africa

Chapter 9 Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

9.3.1 Key Developments

Chapter 10 Company Profiles

10.1 F. Hoffmann-La Roche Ltd

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 SWOT Analysis

10.2 Profacgen

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Amgen Inc.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Novartis AG

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Genscript Biotech

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.6 Pfizer Inc.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.7 Novo Nordisk A/S

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Eli Lilly and Company

10.8.1 Company Overview

10.8.2 Product/Business Segment Overview

10.8.3 Financial Overview

10.8.4 Key Development

10.8.5 SWOT Analysis

10.9 Sanofi S.A.

10.9.1 Company Overview

10.9.2 Product Overview

10.9.3 Financial overview

10.9.4 Key Developments

10.10 Merck & Co., Inc.

10.10.1 Company Overview

10.10.2 Product Overview

10.10.3 Financial overview

10.10.4 Key Developments

10.11 Biogen Inc.

10.11.1 Company Overview

10.11.2 Product Overview

10.11.3 Financial overview

10.11.4 Key Developments

10.12 Others

Chapter 17 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of the Pharmaceutical Industry

Chapter 12 Appendix

LIST OF TABLES

Table 1 Recombinant DNA technology Industry Synopsis, 2020-2027

Table 2 Recombinant DNA Technology Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Recombinant DNA Technology Market, by Region, 2020-2027, (USD Million)

Table 4 Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 5 Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 6 Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 7 Recombinant DNA Technology Market, by End-U.S.er, 2020-2027, (USD Million)

Table 8 North America Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 9 North America Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 10 North America Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 11 North America Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 12 U.S. Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 13 U.S. Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 14 U.S. Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 15 U.S. Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 16 Canada Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 17 Canada Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 18 Canada Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 19 Canada Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 20 South America Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 21 South America Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 22 South America Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 23 South America Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 24 Europe Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 25 Europe Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 26 Europe Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 27 Europe Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 28 Western Europe Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 29 Western Europe Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 30 Western Europe Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 31 Western Europe Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 32 Eastern Europe Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 33 Eastern Europe Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 34 Eastern Europe Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 35 Eastern Europe Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 36 Asia Pacific Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 37 Asia Pacific Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 38 Asia Pacific Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 39 Asia Pacific Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

Table 40 The Middle East & Africa Recombinant DNA Technology Market, by Product, 2020-2027, (USD Million)

Table 41 The Middle East & Africa Recombinant DNA Technology Market, by Component, 2020-2027, (USD Million)

Table 42 The Middle East & Africa Recombinant DNA Technology Market, by Application, 2020-2027, (USD Million)

Table 43 The Middle East & Africa Recombinant DNA Technology Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation of the Recombinant DNA Technology Market

Figure 3 Segmentation Market Dynamics for the Recombinant DNA Technology Market

Figure 4 Global Recombinant DNA Technology Market Share, by Product 2020

Figure 5 Global Recombinant DNA Technology Market Share, by Component 2020

Figure 6 Global Recombinant DNA Technology Market Share, by Application 2020

Figure 7 Global Recombinant DNA Technology Market Share, by End-User2020

Figure 8 Global Recombinant DNA Technology Market Share, by Region, 2020

Figure 9 Americas Recombinant DNA Technology Market Share, by Country, 2020

Figure 10 Europe Recombinant DNA Technology Market Share, by Country, 2020

Figure 11 Asia Pacific Recombinant DNA Technology Market Share, by Country, 2020

Figure 12 Middle East & Africa Recombinant DNA Technology Market Share, by Country, 2020

Figure 13 Global Recombinant DNA Technology Market: Company Share Analysis, 2020 (%)

Figure 14 F. Hoffmann-La Roche Ltd: Key Financials

Figure 15 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 16 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 17 Profacgen: Key Financials

Figure 18 Profacgen: Segmental Revenue

Figure 19 Profacgen: Geographical Revenue

Figure 20 Amgen Inc.: Key Financials

Figure 21 Amgen Inc.: Segmental Revenue

Figure 22 Amgen Inc.: Geographical Revenue

Figure 23 Novartis AG: Key Financials

Figure 24 Novartis AG: Segmental Revenue

Figure 25 Novartis AG: Geographical Revenue

Figure 26 Genscript Biotech: Key Financials

Figure 27 Genscript Biotech: Segmental Revenue

Figure 28 Genscript Biotech: Geographical Revenue

Figure 29 Pfizer Inc.: Key Financials

Figure 30 Pfizer Inc.: Segmental Revenue

Figure 31 Pfizer Inc.: Geographical Revenue

Figure 32 Novo Nordisk A/S: Key Financials

Figure 33 Novo Nordisk A/S: Segmental Revenue

Figure 34 Novo Nordisk A/S: Geographical Revenue

Figure 35 Eli Lilly and Company: Key Financials

Figure 36 Eli Lilly and Company: Segmental Revenue

Figure 37 Eli Lilly and Company: Geographical Revenue

Recombinant DNA Technology Market

Recombinant DNA Technology Market is expected to grow with a CAGR of 7.5% during the forecasted period.

Segmentation

By Product Medical Non Medical
By Component Expression System Cloning Vector
By Application Food & Agriculture Health & Disease
By End-User Biotechnology Companies Pharmaceuticals

Key Players

  • Amgen Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Profacgen (U.S.)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark
  • Genscript Biotech (U.S.)
  • Pfizer Inc. (U.S.)
  • Sanofi S.A. (France)
  • Eli Lilly and Company (U.S.)
  • Biogen Inc. (U.S.)

Drivers

  • Gowing adoption of genetically modified biopesticides and crops
  • Increasing adoption of recombinant DNA technology
Speak to Analyst Request a Free Sample